Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)

NCT01698567 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Challenges enrolling subjects in study

Conditions

Congenital Heart Disease

Interventions

DRUG: Antithrombin III
DRUG: Placebo

Sponsor

University of Rochester